Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation studyVera Golder, Eric F. Morand, Worawit Louthrenoo et al.|The Lancet Rheumatology|2019Cited by 161
Impaired Opsonization with C3b and Phagocytosis of<i>Streptococcus pneumoniae</i>in Sera from Subjects with Defects in the Classical Complement PathwayJosé Yuste, Jeremy Brown, Ashwin Sen et al.|Infection and Immunity|2008Cited by 110